Comparing Distress of Mouse Models for Liver Damage
Authors
Affiliations
In order to foster animal welfare as well as high quality of research, many countries regulate by law that the severity of animal experiments must be evaluated and considered when performing biomedical research. It is well accepted that multiple parameters rather than a single readout parameter should be applied to describe animal distress or suffering. However, since the performance of readout parameters for animal distress is rarely defined and methods for multivariate analysis have only in rare cases been used, it is not known which methodology is most appropriate to define animal distress. This study used receiver operating characteristic curve analysis to quantify the performance of burrowing activity, body weight change and a distress score of mice after induction of liver damage by bile duct ligation or carbon tetrachloride. In addition, Support Vector Machine classification was used to compare the distress of these mouse models. This approach demonstrated that bile duct ligation causes much more distress than carbon tetrachloride-induced liver damage. This study, therefore, provides a prototype how to compare two animal models by considering several readout parameters. In the future these or similar methods for multivariate analysis will be necessary, when assessing and comparing the severity of animal models.
Evidence-Based Severity Assessment of Animal Models for Pancreatic Cancer.
Schreiber T, Koopmann I, Brandstetter J, Talbot S, Goldstein L, Hoffmann L Biomedicines. 2024; 12(7).
PMID: 39062067 PMC: 11275077. DOI: 10.3390/biomedicines12071494.
Ohland P, Jack T, Mast M, Melk A, Bleich A, Talbot S Sci Rep. 2024; 14(1):7198.
PMID: 38531955 PMC: 10965972. DOI: 10.1038/s41598-024-57712-9.
Evaluation of score parameters for severity assessment of surgery and liver cirrhosis in rats.
Krueger J, Habigt M, Helmedag M, Uhlig M, Moss M, Bleich A Anim Welf. 2024; 32:e29.
PMID: 38487427 PMC: 10936376. DOI: 10.1017/awf.2023.21.
Liver fibrosis pathologies and potentials of RNA based therapeutics modalities.
Diwan R, Gaytan S, Bhatt H, Pena-Zacarias J, Nurunnabi M Drug Deliv Transl Res. 2024; 14(10):2743-2770.
PMID: 38446352 DOI: 10.1007/s13346-024-01551-8.
Evidence-based comparative severity assessment in young and adult mice.
Reiber M, von Schumann L, Buchecker V, Boldt L, Gass P, Bleich A PLoS One. 2023; 18(10):e0285429.
PMID: 37862304 PMC: 10588901. DOI: 10.1371/journal.pone.0285429.